MODERN POSSIBILITIES OF THERAPY OF TYPE 2 DIABETES MELLITUS PATIENTS. EFFECTIVENESS AND CARDIOSAFETY OF ALOGLIPTIN FROM THE POINT OF VIEW OF EVIDENCE-BASED MEDICINE

According to the IDF (2016) 1 of 11 adult patients suffers from diabetes mellitus (DM). The total number of diabetic patients is 415 million. By 2040, according to analysts of the International Diabetes Federation, the number of the sick increases and the disease will affect 1 in 10 people. It is ex...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Ametov, E. V. Doskina
Format: Artigo
Language:Russo
Published: Remedium Group LLC 2017-07-01
Series:Медицинский совет
Subjects:
diabetes mellitus type 2
inhibitors dpp 4
alogliptin
cardioesophageal
efficiency
Online Access:https://www.med-sovet.pro/jour/article/view/1933
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items